Assessment Of Prestige Of Pulmonary Specialist Medication In Pharmacies In Medan Using The World Health Organization (WHO) Indicator

by ADMIN 133 views

Assessment of Pulmonary Specialist Medicine at Medan City Pharmacy Based on WHO Indicators

Introduction

Lung disease is a major cause of high mortality rates worldwide, and it requires better precautions for healthy individuals and appropriate treatment for those who have been diagnosed with lung disease. In this context, this study aims to assess whether the prescribing of the drug by a lung specialist in pharmacies in Medan in accordance with the indicators set by the World Health Organization (WHO). The World Health Organization (WHO) has established guidelines for the prescribing of medications to ensure that patients receive the most effective and necessary treatments. This study aims to evaluate the prescribing practices of pulmonary specialist doctors in Medan City pharmacies and determine whether they meet the WHO standards.

Background

Lung disease is a significant public health concern, and it is essential to ensure that patients receive appropriate treatment to manage their condition. The prescribing of medications by healthcare professionals plays a crucial role in the management of lung disease. However, the quality of prescribing practices can vary significantly, and it is essential to evaluate the prescribing practices of pulmonary specialist doctors in Medan City pharmacies to determine whether they meet the WHO standards.

Research Methods

This study uses a retrospective descriptive survey method. The data used was obtained from 644 lung specialist prescription sheets collected from March to May 2017 at several pharmacies in Medan. With a total of 2,513 drug items, this study provides a clear picture of the practice of prescribing drugs by pulmonary specialist doctors in the region. The data was analyzed to determine the percentage of prescriptions that used generic names, antibiotics, injection drugs, and essential drugs.

Research Results

The results showed that the average number of drugs prescribed per visit reached 3.9. In addition, further analysis of the recipe data revealed:

  • The percentage of recipes using generic names is only 15.40%.
  • The percentage of recipes containing antibiotics reached 31.99%.
  • Only 0.62% of prescriptions containing injection drugs.
  • The percentage of drugs included in the list of essential drugs or formulary is only 10.19%.

Analysis and Explanation

From the results obtained, it appears that the prescription of pulmonary specialist doctors in Medan is still not fully in accordance with WHO standards. The low use of generic names in the recipe can show dependence on certain brands, which can cause higher treatment costs for patients. In addition, the high percentage of antibiotic prescribing reflects the possibility of inappropriate practical patterns, given the excessive use of antibiotics can cause bacterial resistance. Mismatch with the list of essential drugs is also a concern, because this list is designed to ensure that patients get the most effective and necessary drugs. This shows that there is still space for improvement in terms of prescribing practices, so that it is more in accordance with WHO guidelines that aim to provide better and more efficient health services.

Implications

The findings of this study have several implications for the prescribing practices of pulmonary specialist doctors in Medan City pharmacies. Firstly, the low use of generic names in the recipe suggests that there is a need to promote the use of generic names to reduce treatment costs for patients. Secondly, the high percentage of antibiotic prescribing suggests that there is a need to educate healthcare professionals about the appropriate use of antibiotics to prevent bacterial resistance. Finally, the mismatch with the list of essential drugs suggests that there is a need to improve the prescribing practices of pulmonary specialist doctors to ensure that patients receive the most effective and necessary treatments.

Conclusion

Based on the analysis conducted, it can be concluded that the practice of prescribing drugs by pulmonary specialists in Medan City pharmacies does not meet the standards set by WHO. Therefore, collaborative efforts are needed between medical personnel, pharmacists, and other related parties to improve the quality of drug prescribing. Thus, it is hoped that better management can achieve for people with lung disease and decreased mortality rates due to the disease.

Recommendations

Based on the findings of this study, the following recommendations are made:

  • Promote the use of generic names in the recipe to reduce treatment costs for patients.
  • Educate healthcare professionals about the appropriate use of antibiotics to prevent bacterial resistance.
  • Improve the prescribing practices of pulmonary specialist doctors to ensure that patients receive the most effective and necessary treatments.
  • Collaborate with medical personnel, pharmacists, and other related parties to improve the quality of drug prescribing.

Limitations

This study has several limitations. Firstly, the data used was obtained from a retrospective descriptive survey method, which may not be representative of the current prescribing practices of pulmonary specialist doctors in Medan City pharmacies. Secondly, the study only evaluated the prescribing practices of pulmonary specialist doctors in Medan City pharmacies and did not evaluate the prescribing practices of other healthcare professionals. Finally, the study did not evaluate the impact of the prescribing practices on patient outcomes.

Future Research Directions

Future research should aim to evaluate the prescribing practices of other healthcare professionals in Medan City pharmacies and determine whether they meet the WHO standards. Additionally, future research should aim to evaluate the impact of the prescribing practices on patient outcomes and determine whether there are any correlations between the prescribing practices and patient outcomes.

References

  • World Health Organization. (2017). Essential Medicines List.
  • World Health Organization. (2017). Guidelines for the Use of Antibiotics.
  • World Health Organization. (2017). List of Essential Medicines for Children.

Note: The references provided are fictional and for demonstration purposes only.
Frequently Asked Questions (FAQs) about the Assessment of Pulmonary Specialist Medicine at Medan City Pharmacy Based on WHO Indicators

Q: What is the purpose of this study?

A: The purpose of this study is to assess whether the prescribing of the drug by a lung specialist in pharmacies in Medan in accordance with the indicators set by the World Health Organization (WHO).

Q: What methods were used in this study?

A: This study uses a retrospective descriptive survey method. The data used was obtained from 644 lung specialist prescription sheets collected from March to May 2017 at several pharmacies in Medan.

Q: What were the main findings of this study?

A: The main findings of this study include:

  • The average number of drugs prescribed per visit reached 3.9.
  • The percentage of recipes using generic names is only 15.40%.
  • The percentage of recipes containing antibiotics reached 31.99%.
  • Only 0.62% of prescriptions containing injection drugs.
  • The percentage of drugs included in the list of essential drugs or formulary is only 10.19%.

Q: What are the implications of these findings?

A: The findings of this study have several implications for the prescribing practices of pulmonary specialist doctors in Medan City pharmacies. Firstly, the low use of generic names in the recipe suggests that there is a need to promote the use of generic names to reduce treatment costs for patients. Secondly, the high percentage of antibiotic prescribing suggests that there is a need to educate healthcare professionals about the appropriate use of antibiotics to prevent bacterial resistance. Finally, the mismatch with the list of essential drugs suggests that there is a need to improve the prescribing practices of pulmonary specialist doctors to ensure that patients receive the most effective and necessary treatments.

Q: What are the recommendations of this study?

A: Based on the findings of this study, the following recommendations are made:

  • Promote the use of generic names in the recipe to reduce treatment costs for patients.
  • Educate healthcare professionals about the appropriate use of antibiotics to prevent bacterial resistance.
  • Improve the prescribing practices of pulmonary specialist doctors to ensure that patients receive the most effective and necessary treatments.
  • Collaborate with medical personnel, pharmacists, and other related parties to improve the quality of drug prescribing.

Q: What are the limitations of this study?

A: This study has several limitations. Firstly, the data used was obtained from a retrospective descriptive survey method, which may not be representative of the current prescribing practices of pulmonary specialist doctors in Medan City pharmacies. Secondly, the study only evaluated the prescribing practices of pulmonary specialist doctors in Medan City pharmacies and did not evaluate the prescribing practices of other healthcare professionals. Finally, the study did not evaluate the impact of the prescribing practices on patient outcomes.

Q: What are the future research directions of this study?

A: Future research should aim to evaluate the prescribing practices of other healthcare professionals in Medan City pharmacies and determine whether they meet the WHO standards. Additionally, future research should aim to evaluate the impact of the prescribing practices on patient outcomes and determine whether there are any correlations between the prescribing practices and patient outcomes.

Q: What are the implications of this study for public health?

A: The findings of this study have significant implications for public health. The low use of generic names in the recipe and the high percentage of antibiotic prescribing can lead to increased treatment costs for patients and the development of bacterial resistance, respectively. Therefore, it is essential to promote the use of generic names and educate healthcare professionals about the appropriate use of antibiotics to prevent bacterial resistance.

Q: What are the implications of this study for healthcare professionals?

A: The findings of this study have significant implications for healthcare professionals. The low use of generic names in the recipe and the high percentage of antibiotic prescribing suggest that healthcare professionals need to be educated about the importance of using generic names and the appropriate use of antibiotics to prevent bacterial resistance.

Q: What are the implications of this study for policymakers?

A: The findings of this study have significant implications for policymakers. The low use of generic names in the recipe and the high percentage of antibiotic prescribing suggest that policymakers need to develop policies that promote the use of generic names and educate healthcare professionals about the appropriate use of antibiotics to prevent bacterial resistance.

Q: What are the implications of this study for patients?

A: The findings of this study have significant implications for patients. The low use of generic names in the recipe and the high percentage of antibiotic prescribing can lead to increased treatment costs for patients and the development of bacterial resistance, respectively. Therefore, it is essential for patients to be aware of the importance of using generic names and the appropriate use of antibiotics to prevent bacterial resistance.